WESLEY GOWERS: Open Payments
NPI 1396581120 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,738 in 126 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $974 · 2025 $2,738
Food & beverage: $2,705Education: $32
| Company | Payments | Amount |
|---|---|---|
| SCPHARMACEUTICALS INC. | 24 | $550 |
| Amgen Inc. | 20 | $531 |
| Calliditas Therapeutics US Inc. | 20 | $462 |
| Otsuka America Pharmaceutical, Inc. | 21 | $329 |
| Novartis Pharmaceuticals Corporation | 8 | $223 |
| SHIELD THERAPEUTICS INC | 6 | $110 |
| Travere Therapeutics, Inc. | 5 | $99 |
| Vifor Pharma, Inc. | 4 | $78 |
| Lilly USA, LLC | 3 | $56 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $54 |
Products named: FUROSCIX, TARPEYO, KRYSTEXXA, JYNARQUE, Vanrafia, TAVNEOS, JARDIANCE, ACCRUFER.
Industry payments across AL — which companies pay providers there.
